UCB (Alprostadil Product Portfolio) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

UCB (Alprostadil Product Portfolio) General Information

Description

Alprostadil medicine portfolio

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Allée de la Recherche, 60
  • 1070 Brussels
  • Belgium
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UCB (Alprostadil Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore UCB (Alprostadil Product Portfolio)‘s full profile, request access.

Request a free trial

UCB (Alprostadil Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore UCB (Alprostadil Product Portfolio)‘s full profile, request access.

Request a free trial